BioSpace News Archive

Root Canal Obturator Market: Rise in root canal treatments to drive the market

Albany NY, United States: Obturation is the technique used to fill and seal a cleaned and shaped root canal with a root canal sealer and core filling material.

May 2, 2022
·
5 min read
Prothrombin Time Testing Market: Rising Prevalence of Peripheral Vascular Treatment Disease to Drive the Market

Albany NY, United States: Owing to a rapidly rising geriatric population and rising demand for point of care testing is leading the global prothrombin time testing market on a higher trajectory.

May 2, 2022
·
5 min read
Microtomes Market: The diagnostic laboratories segment is estimated to hold a leading share of the market

Microtome is a type of sample preparation device used in laboratories. Microtomes are used to prepare thin slices of a sample, which are further processed for study under microscopes.

May 2, 2022
·
6 min read
Business

FSD Pharma Announces Engagement with Tekkfund Capital and Share Issuance to Crystal Research Associates

FSD Pharma Inc. announced today that on April 15th , 2022, the Company entered into a contract with Tekkfund Capital Corp (“ TCC ”) for services to structure and assist with certain business development strategies.

May 2, 2022
·
5 min read
Policy

Extended SpagoPix Patent Protection in USA

Spago Nanomedical AB has received notice from the United States Patent and Trademark Office that it intends to grant the company’s patent application including a critical component of the SpagoPix candidate drug SN132D.

May 2, 2022
·
1 min read
Policy

HUTCHMED Receives Complete Response Letter from the U.S. FDA for Surufatinib for the Treatment of Advanced Neuroendocrine Tumors

HUTCHMED Limited announced that the U.S. Food and Drug Administration has issued a Complete Response Letter regarding the New Drug Application for surufatinib for the treatment of pancreatic and extra-pancreatic neuroendocrine tumors.

May 2, 2022
·
9 min read
BioMidwest

Exact Sciences to participate in May 2022 investor conference

Exact Sciences Corp., a leader in advanced cancer diagnostics, announced that company management will participate in the following conference and invited investors to participate by webcast.

May 2, 2022
·
1 min read
Business

BrainStorm to Announce First Quarter 2022 Financial Results and Provide a Corporate Update

BrainStorm Cell Therapeutics Inc. announced that the Company will hold a conference call to update shareholders on financial results for the first quarter ended March 31, 2022, and provide a corporate update, at 8:00 a.m. Eastern Time on May 16, 2022.

May 2, 2022
·
3 min read
Biotech Beach

Helixmith Announces VM202 (Engensis®) Presentation at New York Academy of Sciences “Advances in Pain” Meeting on May 3, 2022

Helixmith, a gene therapy company based in Seoul, Korea and San Diego, CA, announced an upcoming presentation on their lead plasmid DNA product, Engensis at the NYAS Advances in Pain Meeting on May 3, 2022.

May 2, 2022
·
4 min read
Business

Theravance Biopharma to Report First Quarter 2022 Financial Results on May 5, 2022

Theravance Biopharma, Inc. will report its first quarter 2022 financial results and provide a business update after market close on Thursday, May 5, 2022.

May 2, 2022
·
2 min read